Company Filing History:
Years Active: 2019
Title: János Szolcsányi: Innovator in Neurogenic Inflammation Treatment
Introduction
János Szolcsányi is a notable inventor based in Pécs, Hungary. He has made significant contributions to the field of pharmacology, particularly in the treatment of neurogenic inflammation and neuropathic hyperalgesia. His innovative work has led to the development of new drug candidates that hold promise for effective treatment options.
Latest Patents
János Szolcsányi holds a patent for "Agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders." This invention pertains to 4-phenetylamino-7H-pyrrolo[2,3-d]pyrimidine derivatives, including their solvates, hydrates, and pharmaceutically acceptable salts. The patent outlines processes for manufacturing these compounds, their uses, and pharmaceutical compositions containing them as active agents. These compounds have been identified as potential new drug candidates for preventing and treating acute neurogenic inflammation and neuropathic hyperalgesia.
Career Highlights
Throughout his career, János Szolcsányi has worked with esteemed institutions such as Pécsi Tudományegyetem and Pannonpharma Gyógyszergyártó Kft. His expertise in pharmacology and drug development has positioned him as a key figure in his field.
Collaborations
János has collaborated with notable colleagues, including Erika Pintér and Zsuzsanna Helyes. Their combined efforts have contributed to advancements in the understanding and treatment of neurogenic conditions.
Conclusion
János Szolcsányi's innovative work in developing treatments for neurogenic inflammation and neuropathic hyperalgesia showcases his dedication to improving patient outcomes. His contributions to pharmacology are significant and continue to influence the field.